Eric Rambeaux, CEO of IOME Bio
DiogenX
Visibility and market recognition for biotech startup
Robocath launches new robotic platform R-One+
© Robocath
Yposkesi welcomes French ministers to newly constructed 5,000m2 industrial site – under ‘Choose France’ government scheme
© Courtesy of Yposkesi
DiogenX raises €27.5M Series A financing to advance its first-in-class regenerative treatment for type 1 diabetes towards clinical development
Benjamin Charles, CEO at DiogenX – © DiogenX
Ribonexus appoints Dr. David Howat as Chief Development Officer
David Howat, Chief Development Officer at Ribonexus
Bioxodes presents latest developments at key international conferences – on first-in-class drug candidate for patients with intracerebral hemorrhage
BiPER Therapeutics
Visibility and market recognition for biotech startup